Cadila Healthcare informs about company updates

06 Dec 2019 Evaluate

Cadila Healthcare has informed about inspection by USFDA of the company’s API manufacturing facility located at Dabhasa, Gujarat and company received an Establishment Inspection Report (EIR) which stated that the classification of the facility is ‘No Action Indicated (NAI)’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

881.10 13.30 (1.53%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×